As of August 14, 2026, Attovia Therapeutics, Inc. (ATTO) has a DilutionWatch DilutionScore of 40/100, rated MEDIUM dilution risk.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Score Breakdown
🔄Convertible Debt—
Dilution Forecast
☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for ATTO.
Market Data
Market CapN/A
Shares OutstandingN/A
FloatN/A
CashN/A
DebtN/A
Short InterestN/A
Institutional Holdings
Institutional data not yet available.
Short Interest
Short interest data updating...
Recent SEC Activity
Form 4
INSIDER TRANSACTION
2026-08-06
Form 4
INSIDER TRANSACTION
2026-08-06
Form 4
INSIDER TRANSACTION
2026-08-06
Form 4
INSIDER TRANSACTION
2026-08-06
Form 4
INSIDER TRANSACTION
2026-08-06
Full SEC filing analysis available with free account
→
Recent News
No recent news
Factual ATTO Dilution Snapshot
Attovia Therapeutics, Inc. (ATTO) has a DilutionScore of 40/100, rated Medium dilution risk. Score date: August 14, 2026.
- Recent SEC activity tracked for ATTO: Form 4 on 2026-08-06; Form 4 on 2026-08-06; Form 4 on 2026-08-06.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Track ATTO Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ATTO — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required